| scholarly article | Q13442814 |
| P50 | author | Curtis J Donskey | Q63469953 |
| P2093 | author name string | Donald M Dumford | |
| Mary Ann Richmond | |||
| Michelle Nerandzic | |||
| Shelley Chang | |||
| P2860 | cites work | Fulminant Clostridium difficile colitis in a patient with spinal cord injury: case report | Q80849036 |
| Strategies to prevent clostridium difficile infections in acute care hospitals | Q82229599 | ||
| Reduction of Clostridium Difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods | Q21261741 | ||
| Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates | Q34146714 | ||
| A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality | Q34472139 | ||
| An epidemic, toxin gene-variant strain of Clostridium difficile | Q34472146 | ||
| Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents | Q34690415 | ||
| Clostridium difficile-associated diarrhea in adults | Q35828291 | ||
| The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens | Q35861325 | ||
| Epidemiology of Staphylococcus aureus colonization in nursing home residents | Q35870368 | ||
| Indwelling device use and antibiotic resistance in nursing homes: identifying a high-risk group | Q35870402 | ||
| Community-acquired Clostridium difficile diarrhea caused by binary toxin, toxin A, and toxin B gene-positive isolates in Hungary | Q37511366 | ||
| Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile | Q39459036 | ||
| Rectal swab cultures for Clostridium difficile surveillance studies. | Q40209580 | ||
| Pseudomembranous colitis in spinal cord injury | Q40817518 | ||
| Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin | Q46586095 | ||
| Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain | Q48389186 | ||
| Prevalence of Clostridium difficile colonization at admission to rehabilitation | Q48459651 | ||
| Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. | Q51109086 | ||
| Clostridium difficile-Associated Diarrhea and Colitis | Q60362148 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vancomycin | Q424027 |
| Clostridium difficile | Q310543 | ||
| P304 | page(s) | 22-27 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | The journal of spinal cord medicine : JSCM | Q26853939 |
| P1476 | title | Epidemiology of clostridium difficile and vancomycin-resistant Enterococcus colonization in patients on a spinal cord injury unit | |
| P478 | volume | 34 |
| Q28083860 | Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications |
| Q40332697 | Changes in bacterial epidemiology and antibiotic resistance among veterans with spinal cord injury/disorder over the past 9 years |
| Q41264405 | Clostridium difficile ribotype 078 cultured from post-surgical non-healing wound in a patient carrying ribotype 014 in the intestinal tract. |
| Q37264328 | Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficile |
| Q35592801 | Complicated fecal microbiota transplantation in a tetraplegic patient with severe Clostridium difficile infection |
| Q34862890 | The identification and epidemiology of meticillin-resistant Staphylococcus aureus and Clostridium difficile in patient rooms and the ward environment |
| Q92455864 | Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial |
Search more.